Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SNPX Synaptogenix > Detailed Quotes

SNPX Synaptogenix

7.210
+0.170+2.41%
Close 10/04 16:00 ET
High
7.300
Open
7.280
Turnover
236.69K
Low
7.050
Pre Close
7.040
Volume
32.85K
Market Cap
49.32M
P/E(TTM)
Loss
52wk High
14.500
Shares
6.84M
P/E(Static)
Loss
52wk Low
3.790
Float Cap
45.46M
Bid/Ask %
0.00%
Historical High
14.500
Shs Float
6.30M
Volume Ratio
0.28
Historical Low
3.560
Dividend TTM
--
Div Yield TTM
--
P/B
1.70
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.52%
Amplitude
3.55%
Avg Price
7.206
Lot Size
1
Float Cap
45.46M
Bid/Ask %
0.00%
Historical High
14.500
Shs Float
6.30M
Volume Ratio
0.28
Historical Low
3.560
Dividend TTM
--
P/B
1.70
Dividend LFY
--
Turnover Ratio
0.52%
Amplitude
3.55%
Avg Price
7.206
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Synaptogenix, Inc. operates as a biopharmaceutical company, which engages in the development of a product platform based upon a drug candidate called Bryostatin-1 used for the treatment of Alzheimer’s disease. The firm also evaluates potential therapeutic applications of Bryostatin-1 for other neurodegenerative or cognitive diseases and dysfunctions. The company was founded on October 31, 2012 and is headquartered in New York, NY.
CEO: Mr. Alan J. Tuchman, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...